SGLT-2 Inhibitors in Heart Failure: Volume or Value?
- PMID: 33736820
- DOI: 10.1016/j.jacc.2021.02.005
SGLT-2 Inhibitors in Heart Failure: Volume or Value?
Keywords: SGLT-2 inhibitors; diuretics; heart failure; outcomes; volume.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Kosiborod has received grants, honoraria, and other research support from AstraZeneca; has received grants and honoraria from Boehringer Ingelheim; and has received honoraria from Sanofi, Amgen, NovoNordisk, Merck (Diabetes), Eisai, Janssen, Bayer, GlaxoSmithKline, Glytec, Intarcia, Novartis, Applied Therapeutics, Amarin, and Eli Lilly. Dr. Vaduganathan has received research grant support or served on advisory boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Cytokinetics, and Relypsa; and participates on clinical endpoint committees for studies sponsored by Galmed, Novartis, and the National Institutes of Health.
Comment on
-
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.J Am Coll Cardiol. 2021 Mar 23;77(11):1381-1392. doi: 10.1016/j.jacc.2021.01.033. J Am Coll Cardiol. 2021. PMID: 33736819 Clinical Trial.
Similar articles
-
The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes.Curr Med Res Opin. 2019 Jul;35(7):1283-1295. doi: 10.1080/03007995.2019.1576479. Epub 2019 Feb 15. Curr Med Res Opin. 2019. PMID: 30767677 Review.
-
SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives.Curr Cardiol Rep. 2021 May 7;23(6):59. doi: 10.1007/s11886-021-01486-3. Curr Cardiol Rep. 2021. PMID: 33961133 Review.
-
The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure.Metab Syndr Relat Disord. 2015 Sep;13(7):292-7. doi: 10.1089/met.2015.0038. Epub 2015 Jun 30. Metab Syndr Relat Disord. 2015. PMID: 26125313 Free PMC article. Review.
-
Lessons from SGLT-2 inhibitors: rethinking endpoints for heart failure studies.Nat Med. 2021 Nov;27(11):1872-1873. doi: 10.1038/s41591-021-01565-6. Nat Med. 2021. PMID: 34764484 No abstract available.
-
How Do SGLT-2 Inhibitors Work to Prevent Heart Failure?JACC Heart Fail. 2020 Jan;8(1):67-69. doi: 10.1016/j.jchf.2019.11.009. JACC Heart Fail. 2020. PMID: 31896418 No abstract available.
Cited by
-
Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease.Cardiovasc Diabetol. 2023 Oct 5;22(1):273. doi: 10.1186/s12933-023-01992-4. Cardiovasc Diabetol. 2023. PMID: 37798619 Free PMC article.
-
The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled trials.Int J Clin Pharm. 2023 Jun;45(3):547-555. doi: 10.1007/s11096-022-01504-6. Epub 2023 Feb 17. Int J Clin Pharm. 2023. PMID: 36800144 Review.
-
The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest.Life (Basel). 2022 Dec 8;12(12):2062. doi: 10.3390/life12122062. Life (Basel). 2022. PMID: 36556427 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
